2 completed, 2 unknown, 1 active not recruiting, 1 recruiting. 7 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Completed 2, Unknown 2, Active not recruiting 1, Recruiting 1, Terminated 1 |
Follow Left Ventricular Dysfunction: new trials by email Literature Review of Left Ventricular Dysfunction trials Research Report on Left Ventricular Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| DAPAgliflozine to Attenuate Cardiac RemOdeling afTEr aCuTe myOcardial Infarction Dapagliflozin propanediol (FORXIGA™/FARXIGA™1), Placebo comparator - AMI, STEMI | Phase 3 | Recruiting | Assistance Publique - Hôpitaux de Paris | 450 | 2023-06-12 | 2025-12-19 |
| Myocardial Protection in Patients With Post-acute Inflammatory Cardiac Involvement Due to COVID-19 Prednisolone, Losartan - COVID-19 Associated Cardiac Involvement, Remodeling, Left Ventricle | Phase 3 | Active not recruiting | Valentina Puentmann | 279 | 2022-12-12 | 2025-12-09 |
| Cardioprotective Effects of Nebivolol Versus Placebo in Patients Undergoing Chemotherapy With Anthracyclines Nebivolol, Placebo - Breast Cancer, Lymphoma, Large B-Cell, Diffuse | Phase 3 | Unknown | Giulio Stefanini | 80 | 2019-01-01 | 2023-02-23 |
| Bi Treatment With Hydralazine/Nitrates Versus Placebo in Africans Admitted With Acute Heart Failure Hydralazine, Isosorbide Dinitrate - Acute Heart Failure, Left Ventricular Dysfunction | Phase 3 | Unknown | University of Cape Town | 500 | 2013-01-01 | 2015-08-14 |
| The De-novo Use of Eculizumab in Presensitized Patients Receiving Cardiac Transplantation Eculizumab - Antibody-mediated Rejection, Hyperacute Rejection of Cardiac Transplant | Phase 3 | Completed | Cedars-Sinai Medical Center | 36 | 2012-11-01 | 2021-05-03 |
| INcrease Of VAgal TonE in CHF CardioFit® System, Standard of Care - Left Ventricular Dysfunction, Heart Failure | Phase 3 | Terminated | BioControl Medical | 730 | 2011-02-01 | 2015-12-15 |
| Bone Marrow Derived Mononuclear Cells For Myocardial Regeneration PCI - Left Ventricular Dysfunction | Phase 3 | Completed | Asklepios proresearch | 20 | 2006-02-01 | 2009-07-14 |
Ventricular Dysfunction, Left (7) · Breast Neoplasms (1) · Cardiotoxicity (1) · Complement Component 3 Deficiency, Autosomal Recessive (1) · Heart Failure (1) · Lymphoma, Large B-Cell, Diffuse (1) · Microvascular Angina (1) · Myocardial Infarction (1) · Myocarditis (1) · Non-ST Elevated Myocardial Infarction (1) · Pericarditis (1) · Post-Acute COVID-19 Syndrome (1) · ST Elevation Myocardial Infarction (1) · Vascular Remodeling (1) · Ventricular Remodeling (1)
Cardiovascular Diseases (7) · Heart Diseases (7) · Ventricular Dysfunction (7) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Myocardial Ischemia (3) · Vascular Diseases (3) · Infarction (2) · Ischemia (2) · Necrosis (2) · Angina Pectoris (1) · Breast Diseases (1) · COVID-19 (1) · Cardiomyopathies (1) · Chemically-Induced Disorders (1)
Hydralazine (1) · Isosorbide Dinitrate (1) · Losartan (1) · Nebivolol (1) · Prednisolone (1) · Standard of Care (1) · dapagliflozin (1) · eculizumab (1)
Asklepios proresearch (1) · Assistance Publique - Hôpitaux de Paris (1) · BioControl Medical (1) · Cedars-Sinai Medical Center (1) · Giulio Stefanini (1) · University of Cape Town (1) · Valentina Puentmann (1)
Germany (3) · United States (2) · Austria (1) · Belgium (1) · France (1) · Israel (1) · Italy (1) · Netherlands (1) · Poland (1) · Serbia (1) · South Africa (1) · United Kingdom (1)
Carmelo Carlo-Stella, MD,Prof (1) · Douglas L. Mann, MD (1) · Eike Nagel, MD, PhD (1) · Gad Cotter, MD (1) · Gianluigi Condorelli, MD,PhD,Prof (1) · Giulio G Stefanini, MD,PhD,Prof (1) · Jignesh Patel, M.D., Ph.D. (1) · Karen Sliwa, PhD (1) · Karl-Heinz Kuck, Prof. Dr. med. (1) · Michael Gold (1) · Valentina Puntmann, MD, PhD (1)
PMID 22709747, PMID 27058909, PMID 27206810, PMID 33247624, PMID 33251691, PMID 37182818, PMID 37285278, PMID 42533000
2005 (1)